106006-85-3 Usage
General Description
The chemical (R)-N-(2-amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-propionamide, also known as riluzole, is a medication that is used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. It is thought to work by inhibiting the release of glutamate, which is a neurotransmitter that can cause damage to nerve cells in people with ALS. Riluzole may also have neuroprotective effects, meaning that it helps to protect nerve cells from damage. It is typically taken orally, and common side effects may include dizziness, nausea, and weakness. Riluzole may also interact with certain medications, so it is important to discuss all current medications and medical conditions with a healthcare provider before starting this treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 106006-85-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,0,0 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 106006-85:
(8*1)+(7*0)+(6*6)+(5*0)+(4*0)+(3*6)+(2*8)+(1*5)=83
83 % 10 = 3
So 106006-85-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H15N3OS/c1-2-9(14)12-6-3-4-7-8(5-6)15-10(11)13-7/h6H,2-5H2,1H3,(H2,11,13)(H,12,14)/t6-/m1/s1
106006-85-3Relevant articles and documents
PROCESS FOR PREPARING CHIRALLY PURE 2-AMINO-6-(ALKYL)AMINO-4,5,6,7-TETRAHYDROBENZOTHIAZOLES BY LIQUID CHROMATOGRAPHIC RESOLUTION
-
Page/Page column 17-18, (2008/06/13)
Processes for obtaining single enantiomers of 2-amino-6-(alkyl)amino-4,5,6,7-tetrahydrobenzothiazoles by liquid chromatography are disclosed.